18F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer

被引：0
作者：
J J You
K J Cline
C-S Gu
K I Pritchard
I S Dayes
K Y Gulenchyn
R I Inculet
S K Dhesy-Thind
M A Freeman
A M Chan
J A Julian
M N Levine
机构：
[1] McMaster University,Department of Medicine
[2] McMaster University,Department of Clinical Epidemiology & Biostatistics
[3] Ontario Clinical Oncology Group,Department of Oncology
[4] McMaster University,Department of Medicine
[5] Sunnybrook Odette Cancer Centre,Department of Oncology
[6] University of Toronto,Department of Nuclear Medicine & Molecular Imaging
[7] Juravinski Cancer Centre,Department of Surgery, Division of Thoracic Surgery
[8] Hamilton Health Sciences,Department of Medical Imaging
[9] Hamilton Health Sciences & St Joseph’s Healthcare Hamilton,Department of Oncology
[10] McMaster University,undefined
[11] London Health Sciences Centre,undefined
[12] University of Western Ontario,undefined
[13] 800 Commissioners Road East,undefined
[14] Suite E2-122,undefined
[15] London,undefined
[16] Ontario N6A 5W9,undefined
[17] Canada,undefined
[18] University of Toronto,undefined
[19] University Health Network,undefined
[20] Eaton Wing,undefined
[21] Thunder Bay Regional Health Sciences Centre,undefined
来源：
British Journal of Cancer | 2015年 / 112卷
关键词：
positron-emission tomography; diagnosis; neoplasm recurrence, local; neoplasm metastasis; cohort studies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1737 / 1743
页数：6
相关论文
共 101 条
[1]  
Bjurberg M(2006)FDG-PET in the detection of residual disease and relapse in patients with Hodgkin's lymphoma. Experience from a Swedish centre Acta Oncol 45 743-749
[2]  
Gustavsson A(2001)Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma Oncol Rep 8 1393-1399
[3]  
Ohlsson T(2002)Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden Cancer 94 2766-2792
[4]  
Brun E(2009)Evidence-based approach to the introduction of positron emission tomography in ontario, Canada J Clin Oncol 27 5607-5613
[5]  
Dittmann H(2007)Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus J Nucl Med 48 1251-1258
[6]  
Sokler M(2005)Evaluation of integrated whole-body PET/CT in the detection of recurrent ovarian cancer Eur J Radiol 56 263-268
[7]  
Kollmannsberger C(2008)Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the national oncologic PET registry J Clin Oncol 26 2155-2161
[8]  
Dohmen BM(2013)Intended J Nucl Med 54 2024-2031
[9]  
Baumann C(2005) inferred care after PET performed for initial staging in the National Oncologic PET Registry Breast Cancer Res Treat 90 105-112
[10]  
Kopp A(2007)A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases J Nucl Med 48 28S-35S
12345678910